Advanced Biomed Inc. (ADVB) vs DermTech, Inc. (DMTKQ)

Advanced Biomed Inc. and DermTech, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $8.1M against $3.3M — 2.4× the size. DermTech, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −572.2%) and the higher return on invested capital (−33.4% vs −5,493.5%). Across the 12 metrics below, Advanced Biomed Inc. leads on 11 and DermTech, Inc. on 1.

Valuation

Metric ADVB DMTKQ Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m n/m 4.37
P/B 0.41 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.45 24.35
EV/Sales n/m (2.49) 5.51
Earnings yield 129.37% 0.00% (1.89%)
Free cash flow yield (90.81%) 0.00% (0.15%)

Profitability

Metric ADVB DMTKQ Diagnostics & Research median
Gross margin — 8.51% 50.89%
Operating margin 0.00% (588.62%) (8.57%)
Net margin 0.00% (572.19%) (6.37%)
Free cash flow margin 0.00% (460.10%) 0.00%
Return on equity 84.77% (121.75%) (2.92%)
Return on assets 36.47% (64.00%) (6.71%)
Return on invested capital (33.43%) (5,493.45%) 0.00%

Growth

Metric ADVB DMTKQ Diagnostics & Research median
Revenue growth (TTM) — 9.71% 7.69%
EPS growth (last fiscal year) 266.53% 20.36% 25.92%
Revenue growth, 5-year CAGR — 44.33% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB DMTKQ Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 9.33 3.53 2.02
Net debt to EBITDA 0.06 0.57 0.70

Dividend

Metric ADVB DMTKQ Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB DMTKQ Diagnostics & Research median
Market cap 8.06m 3.29m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack